title: Gatifloxacine-loaded PLGA and β-tricalcium phosphate composite for treating osteomyelitis.
abstract: Gatifloxacine (GFLX)-containing poly(lactide-co-glycolide) (PLGA) was introduced to the pores and surfaces of porous β-tricalcium phosphate (βTCP) granules by melt compounding whereby no toxic solvent was used. The granular composite of GFLX-loaded PLGA and βTCP released GFLX for 42 days in Hanks' balanced solution and exhibited sufficient in vitro bactericidal activity against Streptococcus milleri and Bacteroides fragilis for at least 21 days. For in vivo evaluation, the granular composite was implanted in the dead space created by the debridement of osteomyelitis lesion induced by S. milleri and B. fragilis in rabbit mandible. After a 4-week implantation, the inflammation area within the debrided area was markedly reduced accompanied with osteoconduction and vascularization in half of the rabbits, and even disappeared in one of the six rabbits without any systemic administration of antibiotics. Outside the debrided area, inflammation and sequestrum were observed but the largest of such affected areas amounted to only 0.125 times of the originally infected and debrided area. These findings showed that the granular composite was effective for the local treatment of osteomyelitis as well as an osteoconductive scaffold which supported and encouraged vascularization.
authors: Department of Oral and Maxillofacial Surgery, School of Life Dentistry at Tokyo, The Nippon Dental University, Japan.
authors: Gaku
authors: G
authors: Tamazawa
authors: Atsuo
authors: A
authors: Ito
authors: Takahiro
authors: T
authors: Miyai
authors: Tomonori
authors: T
authors: Matsuno
authors: Kazuki
authors: K
authors: Kitahara
authors: Yu
authors: Y
authors: Sogo
authors: Kaori
authors: K
authors: Kimishima
authors: Tazuko
authors: T
authors: Satoh